Reference
Kao M-W, et al. Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience. International Journal of Molecular Sciences 24: No. 8, Apr 2023. Available from: URL: 10.3390/ijms24087312
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 2000, 45 (2024). https://doi.org/10.1007/s40278-024-54734-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-54734-x